EPISODE · Jul 5, 2019 · 2H 5M
1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma
from Plenary Session - inactive due to federal service · host Vinay Prasad, MD MPH
We begin this week's episode by breaking down the recent phase III trial on voxeletor in sickle cell disease with Dr. Sven Olson of OHSU. Next, we feature guest Dr. David Steensma of the Dana-Farber Cancer Institute in a far-reaching interview on being well-read, running a small lab, humanizing cancer, learning from our past use of erythropoiesis-stimulating agents, understanding the headache of contract research organizations, defining cancer, and more! Voxeletor in Sickle Cell: doi.org/10.1056/NEJMoa1903212 Don't Mention It: doi.org/10.1200/JCO.2008.17.7238 The Raven: doi.org/10.1200/JCO.2017.76.3458 Erythropoietin Use in Cancer: doi.org/10.1200/JCO.2005.05.036 Contract Research Organizations: doi.org/10.1002/cncr.29994 Back us on Patreon! www.patreon.com/plenarysession
Embed this episode
NOW PLAYING
1.68 Voxeletor with Dr. Olson & Humanizing Cancer, Defining Cancer, and more with Dr. David Steensma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.